Use of Enzyme-Inducing Antiseizure Meds May Increase Long-Term CVD Risk
There appears to be a dose-dependent risk for incident cardiovascular disease associated with enzyme-inducing antiseizure medications.
Seizure Disorders
Psychiatric Comorbidities Tied to Higher Mortality in Epilepsy
Researchers assessed the impact of psychiatric morbidities on all-cause mortality in a cohort of adults with epilepsy admitted for video-electroencephalogram monitoring over two decades.
CBD Gel Effective for Seizure Reduction in Children With Encephalopathies
Researchers assessed the safety and tolerability of CBD transdermal gel in pediatric patients with developmental and epileptic encephalopathies, along with its effect on seizure frequency, sleep, and quality of life.
New Position Statement on MRI-Guided Laser Induced Thermotherapy for Epilepsy
The American Society for Stereotactic and Functional Neurosurgery provided a position statement on the use of MRI-guided laser interstitial thermal therapy, a selective ablation procedure, for various types of drug-resistant epilepsy.
Second-Line Home Therapy Outcomes in Patients With Status Epilepticus
In a tertiary analysis, researchers investigated the effects of receiving a second-line anticonvulsant medication that is part of a home regimen on outcomes of patients with refractory convulsive status epilepticus.
Case Study: Increasing Frequency of Nosebleeds Leads to Graves Disease Diagnosis
A 14-year-old adolescent with epilepsy presents with increasing episodes of nosebleeds, increased rate of speech, leg pain with little exercise, and irritable mood. Learn how delayed diagnosis of Graves disease affected her treatment.
Oxcarbazepine Tied to Nontrauma Fracture in Children Aged 4 to 13 With Epilepsy
For children aged 4 to 13 years with epilepsy, initiating oxcarbazepine, ASM is associated with an increased risk for nontrauma fracture.
No Evidence of Increased Suicidality With Common Antiseizure Drug Use
This meta-analysis aimed to evaluate whether there’s evidence that supports the FDA-mandated warning for increased suicidality risk with antiseizure drug usage among people with epilepsy.
Late-Onset Epilepsy Linked to Increased Risk for Death in Older Adults
Researchers explored the risk for death in late-onset epilepsy by analyzing data from the prospective Atherosclerosis Risk in Communities (ARIC) study.
Briviact Approval Expanded to Include Younger Patients with Partial-Onset Seizures
Briviact is now indicated for the treatment of partial-onset seizures in patients 1 month of age and older.
- Loading...
Loading...
Loading... 
Loading...